Skip to main content
. 2022 Dec;10(24):1371. doi: 10.21037/atm-22-6045

Table 2. Results of univariate and multivariate analyses of the validation cohort were performed using the Fine-Gray ratio example distribution hazard model.

Characteristics Define Univariate analysis Multivariate analysis
HR (95% CI) Z (P) HR (95% CI) Z (P)
Age 1.018 (1.014–1.022) 9.222 (<0.001) 1.017 (1.012–1.022) 7.173 (<0.001)
Marriage Married Ref NA Ref NA
Divorced 1.601 (1.387–1.848) 6.436 (<0.001) 1.241 (1.047–1.47) 2.495 (0.013)
Single 2.416 (2.008–2.907) 9.352 (<0.001) 1.252 (0.999–1.57) 1.949 (0.051)
Other 1.804 (1.497–2.173) 6.208 (<0.001) 1.249 (1.021–1.527) 2.162 (0.031)
Race White Ref NA Ref NA
Other 3.655 (2.595–5.149) 7.416 (<0.001) 1.748 (1.165–2.622) 2.697 (0.007)
Sex Female Ref NA Ref NA
Male 1.388 (1.219–1.581) 4.936 (<0.001) 1.139 (0.982–1.322) 1.718 (0.086)
Behavior Behav1 Ref NA Ref NA
Behav2 0.665 (0.575–0.769) −5.499 (<0.001) 0.968 (0.829–1.132) −0.405 (0.69)
Behav3 0.359 (2.446–3.172) 15.436 (<0.001) 1.111 (0.952–1.298) 1.333 (0.18)
Stage I Ref NA Ref NA
II 8.244 (7.021–9.679) 25.747 (<0.001) 2.538 (1.881–3.425) 6.09 (<0.001)
III 17.756 (15.276–20.639) 37.473 (<0.001) 5.821 (4.295–7.888) 11.358 (<0.001)
IV 71.670 (55.927–91.843) 33.760 (<0.001) 6.949 (4.19–11.524) 7.512 (<0.001)
T T1 Ref NA Ref NA
T2 4.428 (3.690–5.314) 15.994 (<0.001) 1.495 (1.125–1.986) 2.774 (0.006)
T3 11.217 (9.445–13.322) 27.554 (<0.001) 1.488 (1.056–2.095) 2.274 (0.023)
T4 23.176 (19.676–27.298) 37.632 (<0.001) 1.868 (1.19–2.931) 2.717 (0.007)
N N0 Ref NA Ref NA
N1 8.186 (6.950–9.642) 25.179 (<0.001) 1.386 (1.119–1.718) 2.990 (0.003)
N2 14.959 (12.197–18.345) 25.981 (<0.001) 1.533 (1.149–2.044) 2.906 (0.004)
Laterality Left Ref NA Ref NA
Right 1.001 (0.882–1.137) 0.022 (0.022) Ref NA
Bilateral 1.027 (0.882–1.196) 0.340 (0.340) Ref NA
Surgery Surg1 Ref NA Ref NA
Surg2 1.937 (1.712–2.191) 10.514 (<0.001) 1.199 (0.566–2.538) 0.473 (0.640)
Surg3 3.035 (2.091–4.405) 5.842 (<0.001) 0.731 (0.35–1.527) −0.834 (0.400)
Surg4 2.482 (2.044–3.013) 9.185 (<0.001) 1.497 (1.174–1.908) 3.259 (0.001)
LNSur No Ref NA Ref NA
LNSur1–3 2.611 (2.256–3.021) 12.877 (<0.001) 0.866 (0.383–1.962) −0.344 (0.730)
LNSur4+ 6.976 (5.474–8.888) 15.710 (<0.001) 0.966 (0.496–1.882) −0.102 (0.920)
LNSur others 2.502 (2.098–2.983) 10.220 (<0.001) 1.009 (0.55–1.85) 0.029 (0.980)
SurgOth No Ref NA Ref NA
Yes 1.709 (1.525–1.913) 9.290 (<0.001) 1.126 (0.652–1.947) 0.427 (0.670)
Pretreatment LDH Low Ref NA Ref NA
Normal level 1.621 (1.354–1.940) 5.270 (<0.001) 0.903 (0.733–1.111) −0.966 (0.330)
Above 2.657 (2.113–3.340) 8.362 (<0.001) 1.133 (0.874–1.468) 0.945 (0.340)
Radiation No Ref NA Ref NA
Yes 16.869 (13.486–21.099) 25.931 (<0.001) 1.876 (1.383–2.546) 4.043 (<0.001)
Chemotherapy No Ref NA Ref NA
Yes 9.194 (7.507–11.260) 21.451 (<0.001) 1.56 (1.186–2.051) 3.181 (0.002)
Mitotic 1.275 (1.261–1.290) 41.035 (<0.001) 1.054 (1.033–1.076) 5.182 (<0.001)
Ulceration 7.589 (6.778–8.498) 35.116 (<0.001) 1.408 (1.211–1.638) 4.436 (<0.001)
LN positive No Ref NA Ref NA
Yes 2.025 (1.710–2.398) 8.180 (<0.001) 0.779 (0.583–1.042) −1.682 (0.093)
Other 0.574 (0.470–0.702) −5.408 (<0.001) 0.89 (0.478–1.658) −0.368 (0.710)
Bone No Ref NA Ref NA
Yes 38.806 (24.615–61.179) 15.752 (<0.001) 1.811 (0.935–3.505) 1.762 (0.078)
Brain No Ref NA Ref NA
Yes 39.498 (25.846–60.359) 41.035 (<0.001) 4.466 (2.456–8.12) 4.905 (<0.001)
Liver No Ref NA Ref NA
Yes 29.086 (18.138–46.644) 13.987 (<0.001) 0.995 (0.501–1.974) −0.015 (0.99)
Breslow 1.419 (1.398–1.441) 44.799 (<0.001) 1.046 (0.993–1.103) 1.687 (0.092)
Lung No Ref NA Ref NA
Yes 24.708 (17.581–34.724) 18.472 (<0.001) 1.176 (0.694–1.995) 0.603 (0.55)
Malignant 1 Ref NA Ref NA
2+ 1.038 (0.924–1.166) 0.632 (0.530) – –

HR, hazard ratio; CI, confidence interval; NA, not available; LNSur, LN surgery; LN, lymph node; SurgOth, surgery other; LDH, lactate dehydrogenase.